×
Nav 1: 19.3107
Date : 20-May-2025
Average AUM : 118.11
| Stock Name | Sector | Value Mn | % of Total Holdings | More Details |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | Pharmaceuticals | 217.9 | 13.65% | |
| Cipla | Pharmaceuticals | 107.5 | 6.74% | |
| Dr Reddys Laboratories | Pharmaceuticals | 103.4 | 6.48% | |
| Apollo Hospitals Enterprises | Hospital | 86.4 | 5.42% | |
| ELI LILLY ORD SHS | Foreign equity | 84.5 | 5.29% | |
| Max Healthcare Institute | Hospital | 82.9 | 5.19% | |
| Divis Laboratories | Pharmaceuticals | 74.6 | 4.67% | |
| Lupin | Pharmaceuticals | 63.4 | 3.97% | |
| Aurobindo Pharma | Pharmaceuticals | 51.5 | 3.23% | |
| Novo Nordisk A/S | Foreign equity | 48.7 | 3.05% | |
| Torrent Pharmaceuticals | Pharmaceuticals | 43.4 | 2.72% | |
| Johnson & Johnson | Foreign equity | 43 | 2.69% | |
| AbbVie Inc | Foreign equity | 37.6 | 2.36% | |
| Fortis Healthcare | Hospital | 34 | 2.13% | |
| Merck & Co Inc Shs | Foreign equity | 32.3 | 2.02% | |
| Mankind Pharma | Pharmaceuticals | 31.2 | 1.96% | |
| Glenmark Pharmaceuticals | Pharmaceuticals | 30.9 | 1.94% | |
| NOVARTIS AG | Foreign equity | 25.7 | 1.61% | |
| Thermo Fisher Scientific Inc | Foreign equity | 25.3 | 1.59% | |
| Ipca Laboratories | Pharmaceuticals | 24.7 | 1.55% | |
| Abbott Laboratories | Foreign equity | 21.3 | 1.33% | |
| Laurus Labs | Pharmaceuticals | 20.4 | 1.28% | |
| Danaher Corporation | Foreign equity | 20.3 | 1.27% | |
| Amgen | Foreign equity | 19.2 | 1.20% | |
| Syngene International | Healthcare research, analytics & technology | 19.1 | 1.20% | |
| Intuitive Surgical | Foreign equity | 18.8 | 1.18% | |
| Biocon | Pharmaceuticals | 18.7 | 1.17% | |
| Gland Pharma | Pharmaceuticals | 17.3 | 1.08% | |
| Jb Chemicals & Pharmaceuticals | Pharmaceuticals | 17.1 | 1.07% | |
| Ajanta Pharma | Pharmaceuticals | 16.9 | 1.06% | |
| DR LAL PATHLABS | Healthcare service provider | 16 | 1.00% | |
| GlaxoSmithKline Pharmaceuticals | Pharmaceuticals | 15.1 | 0.95% | |
| Suven Pharmaceuticals | Pharmaceuticals | 13.7 | 0.86% | |
| Vertex Pharmaceuticals | Foreign equity | 13.7 | 0.86% | |
| Stryker Corporation | Foreign equity | 13.4 | 0.84% | |
| Medtronic Plc | Foreign equity | 12.6 | 0.79% | |
| Narayana Hrudayalaya | Hospital | 11.3 | 0.71% | |
| Global Health | Hospital | 11 | 0.69% | |
| Gilead Sciences | Foreign equity | 10.6 | 0.66% | |
| Pfizer | Pharmaceuticals | 10.3 | 0.64% | |
| Becton Dickinson and Co | Foreign equity | 7.5 | 0.47% | |
| Iqvia Holdings | Foreign equity | 4.9 | 0.31% | |
| Agilent Technologies Inc | Foreign equity | 4.5 | 0.28% | |
| Sanofi Consumer Healthcare India | Pharmaceuticals | 3.4 | 0.21% | |
| Moderna Inc | Foreign equity | 2.7 | 0.17% | |
| ILLUMINA | Foreign equity | 2.2 | 0.14% | |
| Sun Pharmaceutical Industries | Pharmaceuticals | 177.1 | 10.84% | |
| Cipla | Pharmaceuticals | 104 | 6.36% | |
| Dr Reddys Laboratories | Pharmaceuticals | 85.2 | 5.21% | |
| Apollo Hospitals Enterprises | Hospital | 88.6 | 5.43% | |
| ELI LILLY ORD SHS | Foreign equity | 81.9 | 5.01% | |
| Max Healthcare Institute | Hospital | 103.9 | 6.36% | |
| Divis Laboratories | Pharmaceuticals | 84.8 | 5.19% | |
| Lupin | Pharmaceuticals | 50.1 | 3.06% | |
| Aurobindo Pharma | Pharmaceuticals | 31.1 | 1.90% | |
| Novo Nordisk A/S | Foreign equity | 24.8 | 1.52% | |
| Torrent Pharmaceuticals | Pharmaceuticals | 48.8 | 2.99% | |
| Johnson & Johnson | Foreign equity | 59.2 | 3.62% | |
| AbbVie Inc | Foreign equity | 51.6 | 3.16% | |
| Fortis Healthcare | Hospital | 51.8 | 3.17% | |
| Merck & Co Inc Shs | Foreign equity | 29.3 | 1.79% | |
| Mankind Pharma | Pharmaceuticals | 35.4 | 2.17% | |
| Glenmark Pharmaceuticals | Pharmaceuticals | 31.4 | 1.92% | |
| NOVARTIS AG | Foreign equity | 33.3 | 2.04% | |
| Thermo Fisher Scientific Inc | Foreign equity | 25.8 | 1.58% | |
| Ipca Laboratories | Pharmaceuticals | 22.4 | 1.37% | |
| Abbott Laboratories | Foreign equity | 31.9 | 1.95% | |
| Laurus Labs | Pharmaceuticals | 34.8 | 2.13% | |
| Danaher Corporation | Foreign equity | 18.4 | 1.13% | |
| Amgen | Foreign equity | 21.4 | 1.31% | |
| Syngene International | Healthcare research, analytics & technology | 13.1 | 0.80% | |
| Intuitive Surgical | Foreign equity | 23.5 | 1.44% | |
| Biocon | Pharmaceuticals | 21.6 | 1.32% | |
| Gland Pharma | Pharmaceuticals | 16.1 | 0.98% | |
| Jb Chemicals & Pharmaceuticals | Pharmaceuticals | 13.6 | 0.00% | |
| Ajanta Pharma | Pharmaceuticals | 12.5 | 0.77% | |
| DR LAL PATHLABS | Healthcare service provider | 13.3 | 0.00% | |
| GlaxoSmithKline Pharmaceuticals | Pharmaceuticals | 13.7 | 0.84% | |
| Suven Pharmaceuticals | Pharmaceuticals | 10.4 | 0.64% | |
| Vertex Pharmaceuticals | Foreign equity | 13.9 | 0.85% | |
| Stryker Corporation | Foreign equity | 18.6 | 1.14% | |
| Medtronic Plc | Foreign equity | 16.5 | 1.01% | |
| Narayana Hrudayalaya | Hospital | 14.5 | 0.89% | |
| Global Health | Hospital | 12.8 | 0.78% | |
| Gilead Sciences | Foreign equity | 19.5 | 1.19% | |
| Pfizer | Pharmaceuticals | 8.6 | 0.00% | |
| Becton Dickinson and Co | Foreign equity | 7.6 | 0.46% | |
| Iqvia Holdings | Foreign equity | 4.6 | 0.28% | |
| Agilent Technologies Inc | Foreign equity | 4.9 | 0.30% | |
| Sanofi Consumer Healthcare India | Pharmaceuticals | 3.4 | 0.00% | |
| Moderna Inc | Foreign equity | 2.7 | 0.00% | |
| ILLUMINA | Foreign equity | 2.2 | 0.13% | |
| Zydus Lifesciences | Pharmaceuticals | 28.6 | 1.75% | |
| Regeneron Pharmaceuticals | Foreign equity | 8.6 | 0.52% | |
| GRAIL INC | Foreign equity | 0.1 | 0.00% | |
| Alkem Laboratories | Pharmaceuticals | 25.7 | 1.57% | |
| Piramal Pharma | Pharmaceuticals | 12.7 | 0.78% |